by emli1120 | Feb 26, 2024 | 2021, all stories 2021
Infectious Diseases and Hospital Medicine Act Swiftly to Launch Clinical Trials for Remdesivir Less than two months after the World Health Organization characterized COVID-19 as a pandemic, the U.S. Food and Drug Administration (FDA) approved emergency use of...
by emli1120 | Feb 26, 2024 | 2021, all stories 2021
Team Science Initiatives Aim to Investigate ‘Long-Haul COVID’ Two multidisciplinary teams led by Department of Medicine faculty have applied for support to investigate why some people fully recover from COVID-19 while others have long-term effects months later, a...
by emli1120 | Feb 26, 2024 | 2021, all stories 2021
Lung Organoids: A Novel Way to Model COVID Infection A year into the pandemic, we’ve all heard the stories. A patient is a little short of breath but appears to have a mild case of COVID-19. The next day, she deteriorates so rapidly that she’s rushed to intensive...
by emli1120 | Feb 26, 2024 | 2021, all stories 2021
Tofunmi Omiye High Schoolers Show How Data Analysis Can Shape Public Health Policy Tofunmi Omiye High Schoolers Show How Data Analysis Can Shape Public Health Policy Remember the game where you’re given several disparate items and you get two minutes to make up a skit...
by emli1120 | Feb 26, 2024 | 2021, all stories 2021
Talented Women at Every Level of Nephrology A glance at the website for the division of nephrology brings a short paragraph into focus. It includes these three sentences, which could easily be considered a vision statement: “We are devoted to training the next...
by emli1120 | Feb 26, 2024 | 2021, all stories 2021
One Company’s Trash: Nephrology’s Collaboration With Industry in the Fight Against COVID-19 It all started with leftovers. Ascend Clinical laboratories was already taking regular (typically monthly) blood samples of its thousands of dialysis patients from centers all...
